- Home
- WYY vs FGEN Comparison
WYY vs FGEN Comparison
Compare WYY & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- FGEN
- Stock Information
- Founded
- WYY 1991
- FGEN 1993
- Country
- WYY United States
- FGEN United States
- Employees
- WYY N/A
- FGEN N/A
- Industry
- WYY EDP Services
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- WYY Technology
- FGEN Health Care
- Exchange
- WYY Nasdaq
- FGEN Nasdaq
- Market Cap
- WYY 33.4M
- FGEN 33.5M
- IPO Year
- WYY 1998
- FGEN 2014
- Fundamental
- Price
- WYY $3.10
- FGEN $5.69
- Analyst Decision
- WYY Strong Buy
- FGEN Strong Buy
- Analyst Count
- WYY 1
- FGEN 1
- Target Price
- WYY $7.00
- FGEN $250.00
- AVG Volume (30 Days)
- WYY 126.4K
- FGEN 49.2K
- Earning Date
- WYY 08-13-2025
- FGEN 08-05-2025
- Dividend Yield
- WYY N/A
- FGEN N/A
- EPS Growth
- WYY N/A
- FGEN N/A
- EPS
- WYY N/A
- FGEN N/A
- Revenue
- WYY $142,582,209.00
- FGEN $6,996,000.00
- Revenue This Year
- WYY $10.84
- FGEN N/A
- Revenue Next Year
- WYY $12.37
- FGEN N/A
- P/E Ratio
- WYY N/A
- FGEN N/A
- Revenue Growth
- WYY 24.03
- FGEN N/A
- 52 Week Low
- WYY $2.19
- FGEN $4.50
- 52 Week High
- WYY $6.25
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- WYY 40.97
- FGEN 28.80
- Support Level
- WYY $3.01
- FGEN $5.16
- Resistance Level
- WYY $3.41
- FGEN $8.13
- Average True Range (ATR)
- WYY 0.27
- FGEN 0.58
- MACD
- WYY -0.02
- FGEN -0.26
- Stochastic Oscillator
- WYY 7.53
- FGEN 11.13
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.